Senior insider sale
EVP, CHIEF SCIENTIFIC OFFICER at EDITAS MEDICINE, INC. — senior position signals high conviction
$17.8K
6.23K shares
What this filing means
BURKLY LINDA plans to sell 6.23K shares of EDITAS MEDICINE, INC. valued at approximately $17.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/21/2026ACC: 0001650664-26-000074
Officer· EVP, CHIEF SCIENTIFIC OFFICER
Since Mar 2026
6.23K
Shares to sell
$17.8K
Approx. market value
11.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
7/24/2026
11.29KTotal acquired11.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/24/2026 | Restricted Stock Unit Vesting Equity Compensation | 11.29K | — |
| Total | 11.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
731.00
Market value
$2.0K
6/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.50K
Market value
$15.8K
7/27/2026
Total
Units
6.23K
Value
$17.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/3/2026 | 731.00 | $2.0K | — | Completed |
| Planned — Approximate Date | ||||
7/27/2026 | 5.50K | $15.8K | NASDAQ | Planned |
| Total | 6.23K | $17.8K | ||